Nexstim Targets US Stroke Rehab Market With Noninvasive Navigated Brain Therapy
This article was originally published in Clinica
Executive Summary
Finnish noninvasive brain stimulation company Nexstim is eyeing the US as its initial sales market once it completes phase III trial of its Navigated Brain Therapy (NBT) for post-acute stroke treatment.